Skip to main content

Table 6 MeSH terms of HIV/AIDS research papers

From: HIV/AIDS research in Africa and the Middle East: participation and equity in North-South collaborations and relationships

MeSH Term

Global publications

Solely African publications

African + global collaborations

N

%

N

%

N

%

HIV Infections

55,609

80.82

2431

85.48

10,876

90.91

HIV-1

19,945

28.99

378

13.29

2284

19.09

Anti-HIV Agents

12,114

17.61

434

15.26

2647

22.12

Risk Factors

7494

10.89

390

13.71

1525

12.75

Viral Load

6839

9.94

159

5.59

1290

10.78

Antiretroviral Therapy, Highly Active

6758

9.82

327

11.50

1293

10.81

CD4 Lymphocyte Count

6296

9.15

296

10.41

1604

13.41

Prevalence

6172

8.97

463

16.28

1643

13.73

Treatment Outcome

5074

7.37

200

7.03

1091

9.12

Sexual Behavior

4636

6.74

179

6.29

949

7.93

Anti-Retroviral Agents

4529

6.58

196

6.89

1266

10.58

Surveys and Questionnaires

4137

6.01

313

11.01

859

7.18

Acquired Immunodeficiency Syndrome

4047

5.88

253

8.90

524

4.38

Homosexuality, Male

3986

5.79

22

0.77

239

2.00

HIV

3802

5.53

138

4.85

537

4.49

Pregnancy

3728

5.42

287

10.09

1557

13.01

HIV Seropositivity

3604

5.24

241

8.47

787

6.58

RNA, Viral

3497

5.08

48

1.69

467

3.90

Health Knowledge, Attitudes, Practice

3468

5.04

268

9.42

761

6.36

Risk-Taking

3418

4.97

90

3.16

505

4.22

United States

3332

4.84

9

0.32

159

1.33

Coinfection

3238

4.71

204

7.17

673

5.63

South Africa

3197

4.65

832

29.25

2179

18.21

CD4-Positive T-Lymphocytes

3186

4.63

63

2.22

356

2.98

Sexual Partners

3042

4.42

103

3.62

725

6.06

Socioeconomic Factors

2872

4.17

191

6.72

664

5.55

Incidence

2758

4.01

113

3.97

723

6.04

Drug Resistance, Viral

2750

4.00

42

1.48

500

4.18

Virus Replication

2693

3.91

17

0.60

105

0.88

Time Factors

2615

3.80

93

3.27

566

4.73

Genotype

2577

3.75

64

2.25

473

3.95